Fundraising FoxNovalis LifeSciences — 2020 Investments
4 investments dated 2020 · listed companies and verified rows first · show all
Activ Surgical develops intraoperative surgical intelligence technology for surgeons, using AR, AI, machine learning, and sensing to display physiological structures and functions not visible to the naked eye.
AI & Machine LearningHealthtechMedical DevicesBoston, US
Peter Kim(Founder)inMichael Ruehlman(Executive Officer)inTodd Usen(Executive Officer, Director)in
BoardEmily Casey(Director)Ashok Krishnamurthi(Director)inDavid Wells(Director)
Board seatPaul Meister· per SEC Form D · $15M raise · filed Jul 2020
Co-investorsReimagined VenturesAlumni VenturesArtis VenturesBasecamp FundCastor VenturesCota Capital+8 more
Enko discovers and develops novel crop protection products for farmers using a proprietary AI and machine learning discovery platform to combat pests and diseases.
AgTechAI & Machine LearningBiotechBoston, US
Jacqueline Heard(Executive Officer, Director)inTom Meade(Chief Science Officer)Philip Austin(Director)inSteffen Helmling(Director)Anthony Klemm(CEO and Board Director)
Board seatMarijn Dekkers· per SEC Form D
Co-investorsAlumni VenturesCastor VenturesConnecticut InnovationsDYDX CapitalEndeavor8Germin8 Ventures+5 more
Mercy BioAnalytics develops diagnostic tests for early cancer detection using advanced proteomics and genomics technologies.
BiotechDigital HealthHealthtechMedical DevicesNatick, US
Paul Blavin(Co-Founder & Vice Chairman)inStanley Lapidus(Director)inDawn Mattoon, PhD(Chief Executive Officer)Joseph Sedlak(Executive Officer, Director)
BoardSonja Hoel Perkins(Director)in
Board seatPaul Meister· per SEC Form D
Co-investorsAvestria VenturesHatteras Venture PartnersiSelect FundMindshift CapitalPortfoliaSozo Ventures+2 more
Etherna is an RNA-LNP technology company that develops proprietary RNA chemistry and lipid nanoparticle delivery platforms for nucleic acid–based therapeutics, and partners with pharma and biotech organizations from early discovery through clinical development.
BiotechDeep TechMedical DevicesNiel, BE
Co-investorsFund+PMVBoehringer Ingelheim Venture FundEQT Life SciencesOmega FundsPWV
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.